Clinical Trial Update: Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 [Phase 2]

View source ↗

Summary

The University of Michigan is conducting a Phase 2 trial to evaluate tirzepatide for partial lipodystrophy, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Lipodystrophy

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: University of Michigan | Conditions: Lipodystrophy, Partial | Phase 2 | Status: RECRUITING